Arrowstreet Capital Limited Partnership purchased a new stake in Trupanion (NASDAQ:TRUP) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 10,164 shares of the financial services provider’s stock, valued at approximately $298,000.
Other large investors have also modified their holdings of the company. First Mercantile Trust Co. bought a new stake in shares of Trupanion in the fourth quarter valued at about $129,000. JPMorgan Chase & Co. bought a new stake in shares of Trupanion in the third quarter valued at about $143,000. Voya Investment Management LLC bought a new stake in shares of Trupanion in the second quarter valued at about $215,000. Oppenheimer Asset Management Inc. bought a new stake in shares of Trupanion in the third quarter valued at about $221,000. Finally, Wells Fargo & Company MN lifted its stake in shares of Trupanion by 13.5% in the second quarter. Wells Fargo & Company MN now owns 11,261 shares of the financial services provider’s stock valued at $252,000 after buying an additional 1,342 shares during the period. 74.75% of the stock is currently owned by institutional investors.
TRUP traded up $0.38 during midday trading on Friday, reaching $27.02. 618,798 shares of the company’s stock were exchanged, compared to its average volume of 373,067. The stock has a market cap of $802.62, a price-to-earnings ratio of -386.00 and a beta of 0.57. The company has a quick ratio of 1.89, a current ratio of 1.89 and a debt-to-equity ratio of 0.19. Trupanion has a one year low of $14.27 and a one year high of $37.13.
Trupanion (NASDAQ:TRUP) last posted its earnings results on Tuesday, February 13th. The financial services provider reported ($0.05) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.03). Trupanion had a negative net margin of 0.62% and a negative return on equity of 6.66%. The firm had revenue of $66.55 million during the quarter, compared to the consensus estimate of $65.60 million. equities research analysts expect that Trupanion will post -0.05 EPS for the current fiscal year.
Several equities research analysts recently weighed in on TRUP shares. BidaskClub upgraded shares of Trupanion from a “hold” rating to a “buy” rating in a research note on Monday, December 18th. Stifel Nicolaus reiterated a “buy” rating and issued a $34.00 target price (up previously from $33.00) on shares of Trupanion in a research note on Wednesday, February 14th. Lake Street Capital raised their price target on shares of Trupanion from $32.00 to $41.00 and gave the stock a “buy” rating in a research note on Wednesday, February 14th. Cowen restated an “outperform” rating and set a $38.00 price target (up previously from $32.00) on shares of Trupanion in a research note on Wednesday, February 14th. Finally, Zacks Investment Research cut shares of Trupanion from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company. Trupanion has an average rating of “Buy” and an average price target of $35.57.
In related news, Director Murray B. Low sold 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $28.42, for a total value of $85,260.00. Following the completion of the sale, the director now owns 194,281 shares of the company’s stock, valued at $5,521,466.02. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Darryl Rawlings sold 3,500 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $34.36, for a total transaction of $120,260.00. Following the completion of the sale, the insider now directly owns 1,382,976 shares of the company’s stock, valued at approximately $47,519,055.36. The disclosure for this sale can be found here. Insiders sold 21,000 shares of company stock valued at $654,865 in the last quarter. 31.24% of the stock is currently owned by corporate insiders.
ILLEGAL ACTIVITY NOTICE: This piece of content was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/04/07/arrowstreet-capital-limited-partnership-invests-298000-in-trupanion-inc-trup.html.
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.